Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Substance Use Disorders (SUDs)
Interventions
OTHER

Cogito digital therapeutics development platform

Cogito will provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment and/or management of any disease or disorder. This platform will allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide all the components for building a digital therapeutic for any health condition and population. Overall, Cogito offers great promise to markedly accelerate the pace and impact of science based digital therapeutics.

Trial Locations (1)

03755

RECRUITING

Square 2 Systems, Hanover

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Square2 Systems, Inc.

INDUSTRY

NCT07104396 - Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics | Biotech Hunter | Biotech Hunter